VirnetX Holding Corp
For the period ended Dec 31, 2025. Filed Mar 24, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Mar 24, 2026
VHC$9.25-6.8%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits and Financial Statement Schedules
| Item 15. | Exhibits and Financial Statement Schedules |
|---|
| (1) | Financial Statements: See the Index to Consolidated Financial Statements under Item 8 of this Annual Report on Form 10-K. |
| (2) | Financial Statement Schedule: Financial statement schedules are omitted because they are not applicable, or the required information is shown in the financial statements or notes thereto. All other schedules are omitted because of the absence of conditions under which they are required or because the required information is given in the financial statements or the notes thereto. |
| (3) | Exhibits: The documents listed in the Exhibit Index of this Annual Report on Form 10-K are incorporated by reference or are filed with this Annual Report on Form 10-K, in each case as indicated therein (numbered in accordance with Item 601 of Regulation S-K). |
Index
EXHIBIT INDEX
| Exhibit Number · Description · Incorporated by reference herein | ||||||
|---|---|---|---|---|---|---|
| Form · Exhibit No. · Filing Date · File No. · Filed Herewith | ||||||
| 3.1 | Amended and Restated Certificate of Incorporation of the Company, as amended. | 8-K | 3.1 | 11/01/2007 | 000-26895 | |
| 3.2 | Certificate of Amendment to the Amended and Restated Certificate of Incorporation of the Company. | 8-K | 3.1 | 10/25/2023 | 001-33852 | |
| 3.3 | Amended and Restated Bylaws of the Company. | 8-K | 3.1 | 01/27/2023 | 001-33852 | |
| 4.1 | Specimen Common Stock Certificate. | S-3 | 4.1 | 07/30/2018 | 333-226413 | |
| 4.2 | Form of Senior Indenture. | S-3 | 4.2 | 07/30/2018 | 333-226413 | |
| 4.3 | Form of Subordinated Indenture. | S-3 | 4.4 | 07/30/2018 | 333-226413 | |
| 4.4 | Description of Capital Stock. | X | ||||
| 10.1 | Form of Indemnification Agreement. | 10-K | 10.1 | 03/18/2019 | 001-33852 | |
| 10.2* | 2007 Stock Plan, as amended. | 10-Q | 10.2 | 05/10/2012 | 001-33852 | |
| 10.3* | Amended Form of Stock Option Agreement – 2007 Stock Plan. | 10-Q | 4.5 | 05/10/2011 | 001-33852 | |
| 10.4* | Form of Restricted Stock Unit Award Agreement – 2007 Stock Plan. | 10-Q | 10.3 | 05/10/2012 | 001-33852 | |
| 10.5* | 2013 Equity Incentive Plan, as amended. | DEF 14A | Appendix A | 04/13/2021 | 001-33852 | |
| 10.6* | Amended and Restated 2013 Equity Incentive Plan. | 8-K | 10.1 | 06/18/2024 | 001-33852 | |
| 10.7* | Form of Stock Option Agreement – 2013 Equity Incentive Plan and Amended and Restated 2013 Equity Incentive Plan. | 10-K | 10.6 | 03/02/2015 | 001-33852 | |
| 10.8* | Form of Restricted Stock Unit Agreement – 2013 Equity Incentive Plan and Amended and Restated 2013 Equity Incentive Plan. | 10-K | 10.7 | 03/02/2015 | 001-33852 | |
| 10.9* | Form of Restricted Stock Agreement – Amended and Restated 2013 Equity Incentive Plan. | 10-Q | 10.2 | 08/11/2023 | 001-33852 | |
| 10.10 | Patent License and Assignment Agreement by and between the Company and Leidos, Inc. (formerly Science Applications International Corporation) dated as of August 12, 2005. | 8-K | 10.4 | 07/12/2007 | 000-26895 | |
| 10.11** | Amendment No. 1 to Patent License and Assignment Agreement by and between the Company and Leidos, Inc. dated as of November 2, 2006. | 8-K | 10.6 | 07/12/2007 | 000-26895 | |
| 10.12 | Amendment No. 2 to Patent License and Assignment Agreement by and between VirnetX, Inc. and Leidos, Inc. dated as of March 12, 2008. | 8-K | 10.1 | 03/18/2008 | 001-33852 | |
| 10.13 | Security Agreement by and between the Company and Leidos, Inc. dated as of August 12, 2005. | 8-K | 10.5 | 07/12/2007 | 000-26895 | |
| 10.14 | Assignment Agreement between the Company and Leidos, Inc. dated as of December 21, 2006. | 8-K | 10.7 | 07/12/2007 | 000-26895 | |
Index
| 10.15 | Professional Services Agreement by and between the Company and Leidos, Inc. dated as of August 12, 2005. | 8-K | 10.8 | 07/12/2007 | 000-26895 |
| 10.16** | Settlement and License Agreement, by and between Microsoft Corporation and VirnetX, Inc., dated May 14, 2010. | 10-Q/A | 10.1 | 01/31/2011 | 001-33852 |
| 10.17** | Amended Settlement and License Agreement, by and between Microsoft Corporation and VirnetX, Inc., dated December 17, 2014. | 10-K | 10.23 | 03/02/2015 | 001-33852 |
|---|---|---|---|---|---|
| 10.18* | Hire Letter by and between Katherine Allanson and the Company, dated as of September 1, 2021. | 10-Q | 10.1 | 11/08/2021 | 001-33852 |
| 10.19 | Warrant to Purchase Shares of Common Stock of the Company by and between the Company and Odeon Capital Group LLC, dated as of April 29, 2020. | 10-Q | 10.2 | 05/15/2023 | 001-33852 | |
| 10.20* | Outside Director Compensation Policy, as adopted on November 30, 2023. | 10-K/A | 10.22 | 04/18/2024 | 001-33852 | |
| 19.1 | Insider Trading and Disclosure Compliance Program, amended on August 11, 2025. | X | ||||
| 21.1 | Subsidiaries of VirnetX Holding Corporation. | 10-K | 21.1 | 03/16/2021 | 001-33852 | |
| 23.1 | Consent of Farber Hass Hurley LLP, Independent Registered Public Accounting Firm. | X | ||||
| 24.1 | Power of Attorney (contained on signature page hereto) | X | ||||
| 31.1 | Chief Executive Officer Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act. | X | ||||
| 31.2 | Chief Financial Officer Certification pursuant to Rule 13a-14(a) of the Securities Exchange Act. | X | ||||
| 32.1† | Chief Executive Officer Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 | X | ||||
| 32.2† | Chief Financial Officer Certification pursuant to 18 U.S.C. Section 1350 as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002. | X | ||||
| 97.1* | Compensation Recovery Policy of the Company as adopted November 8, 2023. | 10-K/A | 97.1 | 04/18/2024 | 001-33852 | |
| 101.INS | XBRL Instance Document | X | ||||
| 101.SCH | XBRL Taxonomy Extension Schema Document | X | ||||
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | X | ||||
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | X | ||||
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document | X | ||||
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | |||||
| 104 | Cover Page Interactive Data File (formatted as inline XBRL and contained in Exhibit 101) | X | ||||
| * | Indicates management contract or compensatory plan. |
|---|
| ** | Confidential treatment has been granted by the SEC as to certain portions of this exhibit. |
|---|
| † | The certifications attached as Exhibit 32.1 and 32.2 that accompany this Report are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of VirnetX Holding Corporation under the Securities Act or the Exchange Act, whether before or after the date of this Report, irrespective of any general incorporation language contained in such filing. |
|---|
Index
SIGNATURES
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange Act of 1934, the registrant has duly caused this Annual Report on Form 10-K to be signed on its behalf by the undersigned, thereunto duly authorized.
| VirnetX Holding Corporation | |
| By: | /s/ Kendall Larsen |
| Name: Kendall Larsen | |
| Title: Chief Executive Officer and President |
Index
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.